Possibilities of combined inhalation therapy of infectious and inflammatory diseases of the upper respiratory tract
S.V. Morozova, D.B. Bidanova

Sechenov University, Moscow

Unreasonable prescription of systemic antibacterial drugs in the treatment of infectious and inflammatory diseases of the upper respiratory tract leads to increased levels of antibiotic resistance. In the overwhelming majority of cases, systemic antibacterial therapy for acute rhinosinusitis is not indicated, since acute rhinosinusitis is viral in 90% of cases. In chronic rhinosinusitis, the prescription of systemic antibiotic therapy should be strictly justified. An alternative to the systemic administration of antibiotics for rhinosinusitis is topical antimicrobial application. The combination drug Fluimucil^®-antibiotic IT, which includes the N-acetylcysteine mucolytic and thiamphenicol, broad-spectrum antibiotic, is highly effective in treating inflammatory diseases of the upper respiratory tract. The use of the drug Fluimucil^®-antibiotic IT for rhinosinusitis allows you to accelerate the onset of convalescence, to avoid systemic antibiotic therapy and invasive procedures.

Key words: rhinosinusitis, inhalation therapy, topical therapy, antibiotic therapy, thiamphenicol glycinate acetylcysteine, Fluimucil^®-antibiotic IT.
For citation: Morozova S.V., Bidanova D.B. Possibilities of combined inhalation therapy of infectious and inflammatory diseases of the upper respiratory tract // RMJ. 2018. № 10(II). P. 50–53.